azacitidine and bmn 673

azacitidine has been researched along with bmn 673 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Baer, MR; Baylin, SB; Bentzen, SM; Duong, VH; Emadi, A; Kogan, AA; Lapidus, RG; Mi, T; Niyongere, S; O'Connell, CL; Rassool, FV; Youngblood, BA1

Trials

1 trial(s) available for azacitidine and bmn 673

ArticleYear
Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 04-01, Volume: 28, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Decitabine; DNA; Humans; Leukemia, Myeloid, Acute; Methyltransferases; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors

2022